Annual report pursuant to Section 13 and 15(d)

Acquisition of Emerald Health Therapeutics, Inc - Schedule of Asset Acquisition (Details)

v3.23.1
Acquisition of Emerald Health Therapeutics, Inc - Schedule of Asset Acquisition (Details) - USD ($)
 12 Months Ended
Nov. 10, 2022
Dec. 31, 2022
Asset Acquisition [Line Items]    
Transaction costs   $ 1,475,144
Emerald Health Therapeutics Inc    
Asset Acquisition [Line Items]    
Common stock $ 9,574,222  
EHT rollover stock options 105,929  
EHT rollover warrants 203,515  
Transaction costs 1,552,490  
Total consideration 11,436,156  
Cash and cash equivalents 6,784,057  
Accounts receivable 14,375  
Prepaid Expenses 4,227  
Assets held for sale 6,610,662  
Related party loan 680,901  
Other current assets 356,961  
Accounts payable (909,048)  
Short term liability 557,010  
Payroll liabilities (577,421)  
Insurance premium loan payable (89,851)  
Tax liabilities (158,858)  
Other current liabilities (722,839)  
Total net assets acquired $ 11,436,156